Publications
Detailed Information
EVORPACEPT (ALX148), A CD47 MYELOID CHECKPOINT INHIBITOR, IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) AND WITH GASTRIC/GASTROESOPHAGEAL CANCER (GC); ASPEN-01
Cited 4 time in
Web of Science
Cited 0 time in Scopus
- Authors
- Issue Date
- 2021-11
- Publisher
- BioMed Central
- Citation
- Journal for ImmunoTherapy of Cancer, Vol.9, pp.A530-A530
- ISSN
- 2051-1426
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.